Exhibit 97.1
AILERON THERAPEUTICS, INC.
Compensation Recovery Policy
This Compensation Recovery Policy (this “Policy”) is adopted by Aileron Therapeutics, Inc. (the “Company”) in accordance with Nasdaq Listing Rule 5608 (“Rule 5608”). This Policy is effective as of October 2, 2023 (the “Effective Date”).
Subject to the terms of this Policy and the requirements of Rule 5608, if the Company is required to prepare an Accounting Restatement, the Company will attempt to recover, reasonably promptly from each Covered Person, any Erroneously Awarded Compensation that was Received by such Covered Person during the Recovery Period pursuant to Incentive-Based Compensation that is subject to this Policy.
Adopted by the Board on November 28, 2023.
* * * * *